American Heart Journal
Volume 143, Issue 5 , Pages 790-796 , May 2002

Early recanalization and plasma brain natriuretic peptide as an indicator of left ventricular function after acute myocardial infarction

Received 1 April 2001 ,Accepted 3 December 2001.

References 

  1. Tan AC, van Loenhout T, Lamfers EJ, et al.  Atrial natriuretic peptide after myocardial infarction. Am Heart J. 1989;118:490–494
  2. Jougasaki M, Yasue H, Mukoyama M, et al.  Appearance of atrial natriuretic peptide in the ventricles in patients with myocardial infarction. Am Heart J. 1990;119:92–96
  3. Mukoyama M, Nakao K, Obata K, et al.  Augmented secretion of brain natriuretic peptide in acute myocardial infarction. Biochem Biophys Res Commun. 1991;180:431–436
  4. Morita E, Yasue H, Yoshimura M, et al.  Increased plasma levels of brain natriuretic peptide in patients with acute myocardial infarction. Circulation. 1993;88:82–91
  5. Arakawa N, Nakamura M, Aoki H, et al.  Relationship between plasma level of brain natriuretic peptide and myocardial infarct size. Cardiology. 1994;127:334–340
  6. Kettunen RV, Leppäluoto J, Jounela A, et al.  Plasma N-terminal atrial natriuretic peptide in acute myocardial infarction. Am Heart J. 1994;127:1449–1455
  7. Omland T, Aasland T, Aakvaag A, et al.  Prognostic value of plasma atrial natriuretic factor, norepinephrine and epinephrine in acute myocardial infarction. Am J Cardiol. 1993;72:255–259
  8. Omland T, Bonarjee VV, Nilson DW, et al.  Prognostic significance of N-terminal pro-atrial natriuretic factor (1-99) in acute myocardial infarction: comparison with atrial natriuretic factor (99-126) and clinical evaluation. Br Heart J. 1993;70:409–414
  9. Hall C, Rouleau JL, Moyé LA, et al.  N-terminal proatrial natriuretic factor: an independent predictor of long-term prognosis after myocardial infarction. Circulation. 1994;89:1934–1942
  10. Rouleau JL, Packer M, Moyé LA, et al.  Prognostic value of neurohumoral activation in patients with an acute myocardial infarction: effect of captopril. J Am Coll Cardiol. 1994;24:583–591
  11. Omland T, Bonarjee VV, Lie RT, et al.  Neurohumoral measurements as indicators of long-term prognosis after myocardial infarction. Am J Cardiol. 1995;76:230–235
  12. Omland T, Aakvaag A, Bonarjee VV, et al.  Plasma brain natriuretic peptide as an indicator of left ventricular systolic function and long-term survival after acute myocardial infarction: comparison with plasma atrial natriuretic peptide and N-terminal proatrial natriuretic peptide. Circulation. 1996;93:1963–1969
  13. Sumida H, Yasue H, Yoshimura M, et al.  Comparison of secretion pattern A-type and B-type natriuretic peptides in patients with old myocardial infarction. J Am Coll Cardiol. 1995;25:1105–1110
  14. ISIS-2 collaborative group . Randomized trial of intravenous streptokinase, oral aspirin or both or neither among 17,187 cases of suspected acute myocardial infarction. Lancet. 1988;2:349–360
  15. White HD, Norris RM, Brown MA, et al.  Effect of intravenous streptokinase on left ventricular function and early survival after acute myocardial infarction. N Engl J Med. 1987;317:850–855
  16. Yasue H, Yoshimura M, Sumida H, et al.  Localization and mechanism of secretion of B-type natriuretic peptide in comparison with those of A-type natriuretic peptide in normal subjects and patients with heart failure. Circulation. 1994;90:195–203
  17. Richard AM, Nicholls MG, Yandle TG, et al.  Neuroendocrine prediction of left ventricular function and heart failure after acute myocardial infarction. The Christchurch Cardioendocrine Research Group. Heart. 1999;81:114–120
  18. Kinnunen P, Vuolteenaho O, Ruskoaho H. Mechanism of atrial and brain natriuretic peptide release from rat ventricular myocardium: effect of stretching. Endocrinology. 1993;132:1961–1970
  19. Richard AM, Crizier IG, Yandle TG, et al.  Brain natriuretic factor: regional plasma concentrations and correlations with haemodynamic state in cardiac disease. Br Heart J. 1993;69:414–417
  20. Magga J, Vuolteenaho O, Takola H, et al.  B-type natriuretic peptide: a myocyte-specific marker for characterizing load-induced alterations in cardiac gene expression. Ann Med. 1998;30(suppl 1):39–45
  21. Horio T, Shimada K, Kohno M, et al.  Serial changes in atrial and brain natriuretic peptides in patients with acute myocardial infarction treated with early coronary angioplasty. Am Heart J. 1993;126:293–299
  22. Hama N, Itoh H, Shirakami G, et al.  Rapid ventricular induction of brain natriuretic peptide in patients with acute myocardial infarction. Circulation. 1995;92:1558–1564
  23. Arakawa N, Nakamura M, Aoki H, et al.  Plasma brain natriuretic peptide concentrations predict survival after acute myocardial infarction. J Am Coll Cardiol. 1996;27:1656–1661
  24. Remes J. Neuroendocrine activation after myocardial infarction. Br Heart J. 1994;72(suppl 3):65–69
  25. Swedberg K, Held P, Kjekshus J, et al.  Effects of the early administration of enalapril on mortality in patients with acute myocardial infarction. N Engl J Med. 1992;327:678–684
  26. Packer M, Bristow MR, Cohn JN, et al.  The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. N Engl J Med. 1996;334:1349–1355
  27. Troughton RW, Frampton CM, Yandle TG, et al.  Treatment of heart failure guided plasma aminoterminal brain natriuretic peptide (N-BNP) concentration. Lancet. 2000;355:1126–1130

☆ Reprint requests: Teruo Inoue, MD, Department of Cardiology, Koshigaya Hospital, Dokkyo University School of Medicine, 2-1-50 Minamikoshigaya, Koshigaya-City, Saitama 343-8555, Japan.

PII: S0002-8703(02)03957-1

doi: 10.1067/mhj.2002.122170

American Heart Journal
Volume 143, Issue 5 , Pages 790-796 , May 2002

Article Tools

* Image Usage & Resolution